相关实验视频

Updated: May 30, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

乳腺癌中的m6A相关代谢基因及其与预后的关系

Yong Tao¹, Qin Wang¹, Shenchao Guo¹

¹Department of Colorectal Surgery, The First Affiliated Hospital of Ningbo University Ningbo Zhejiang China.

International immunopharmacology

|January 31, 2025

概括

N6-甲基氨酸 (m6A) 代谢基因调节乳腺癌 (BC) 的进展. 这项研究确定了关键的预后基因和BC的风险模型,提供了新的治疗点和改进的临床管理策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

乳腺癌 (BC) 是女性癌症死亡的主要原因,其发病率每年都在增加.
N6-甲基氨酸 (m6A) 修改是BC发育和进展的关键调节者.
在BC中m6A相关代谢基因 (mMGs) 的特定作用尚未完全理解.

研究的目的:

调查mMGs在BC法规中的功能.
确定新的预后生物标志物和BC的治疗点.
开发基于mMGs的BC风险预测模型.

主要方法:

从BC患者的外周血液中分析单细胞RNA测序 (scRNA-seq) 数据.
使用scRNA-seq和癌症基因组图谱 (TCGA) 的基因表达数据识别差异表达的mMGs (DEmMGs).
使用拉索 - 考克斯回归和通过qRT-PCR和西方 blot验证预后基因的BC风险模型的构建.

主要成果:

根据它们的表达,识别DEmMGs,然后根据它们的表达,对BC亚型进行聚类.
开发一种与预后,免疫微环境和药物敏感性相关的BC风险模型.
验证了六个关键的预后基因 (NDUFAB1,VDAC1,TYMP,UGDH,ATP6AP1,ALDH2) 在BC中表达的显著差异.

结论:

mMGs在BC病原和进展中发挥着重要作用.
鉴定的风险模型和预后基因为BC诊断,预后和向治疗提供了潜在的工具.
这项研究为治疗干预和乳腺癌的临床管理提供了新的途径.

关键词:

乳腺癌是什么? 乳腺癌是什么?这是一种N6-甲基氨酸.这是NMFNMF的NMF.在RNA-seqqq.这就是 scRNA-seqq.

更多相关视频

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...